MarkJ.RoutbortMD

PubMed

• Intragenic.E1E8 Fusion (EGFRvIII) in 4331 Solid Tumors.
  Zheng, L., Luthra, R., Alvarez, H., San Lucas, F., Duose, D., Wistuba, I., Fuller, G., Ballester, L., Roy-Chowdhuri, S., Sweeney, K., Rashid, A., Yang, R., Chen, W., L...> ;Cancers. 2023 Dec 19
• 1 citations
  mutations in myeloid neoplasms differ by disease subtypes but characterize a subset of chronic myeloid neoplasms with eosinophilia and/or basophilia.
  C Cameron Yin, Wayne Tam, Serena M Walker, Amandeep Kaur, Madhu M Ouseph, Wei Xie, Olga K Weinberg, Peng Li, Zhuang Zuo, Mark J Routbort, Simon Chen, L Jeffrey Medeiro...> ;Haematologica. 2023 Nov 16
• Detection of clinically actionable gene fusions by next-generation sequencing-based RNA sequencing of non-small cell lung cancer cytology specimens: A single-center ex...
  John Diks, Zhenya Tang, Mehmet Altan, Sarah Anderson, Hui Chen, Asif Rashid, Richard Kenneth Yang, Mark J Routbort, Keyur P Patel, Gokce A Toruner, L Jeffrey Medeiros,...> ;Cancer Cytopathology. 2024 Jan 1
• 12 citations
  The NCI-MATCH trial: lessons for precision oncology.
  Peter J O'Dwyer, Robert J Gray, Keith T Flaherty, Alice P Chen, Shuli Li, Victoria Wang, Lisa M McShane, David R Patton, James V Tricoli, P Mickey Williams, A John Iaf...> ;Nature Medicine. 2023 Jun 1
• 2 citations
  DDX41 mutations in patients with non-myeloid hematologic neoplasms.
  Fatima Zahra Jelloul, Mark J Routbort, Courtney D DiNardo, Carlos E Bueso-Ramos, Rashmi Kanagal-Shamanna, Beenu Thakral, Zhuang Zuo, C Cameron Yin, Sanam Loghavi, Chi ...> ;American Journal of Hematology. 2023 Aug 1
• 14 citations
  Efficacy and clinicogenomic correlates of response to immune checkpoint inhibitors alone or with chemotherapy in non-small cell lung cancer.
  Lingzhi Hong, Muhammad Aminu, Shenduo Li, Xuetao Lu, Milena Petranovic, Maliazurina B Saad, Pingjun Chen, Kang Qin, Susan Varghese, Waree Rinsurongkawong, Vadeerat Rin...> ;Nature Communications. 2023 Feb 8
• Concurrent Mutations inandin Myeloid Neoplasms.
  Zhuang Zuo, L Jeffrey Medeiros, Sofia Garces, Mark J Routbort, Chi Young Ok, Sanam Loghavi, Rashmi Kanagal-Shamanna, Fatima Zahra Jelloul, Guillermo Garcia-Manero, Kel...> ;Biology. 2022 Dec 21
• 6 citations
  Recommendations for the Use of in Silico Approaches for Next-Generation Sequencing Bioinformatic Pipeline Validation: A Joint Report of the Association for Molecular P...
  Eric J Duncavage, Joshua F Coleman, Monica E de Baca, Sabah Kadri, Annette Leon, Mark Routbort, Somak Roy, Carlos J Suarez, Chad Vanderbilt, Justin M Zook> ;The Journal of Molecular Diagnostics. 2023 Jan 1
• 6 citations
  Clinical Testing for Mismatch Repair in Neoplasms Using Multiple Laboratory Methods.
  Richard K Yang, Hui Chen, Sinchita Roy-Chowdhuri, Asif Rashid, Hector Alvarez, Mark Routbort, Keyur P Patel, Raja Luthra, L Jeffrey Medeiros, Gokce A Toruner> ;Cancers. 2022 Sep 20
• Distinct Gene Mutations Are Associated With Clinicopathologic Features in Urachal Carcinoma.
  Michael P Zaleski, Hui Chen, Sinchita Roy-Chowdhuri, Keyur P Patel, Rajyalakshmi Luthra, Mark J Routbort, Ashish M Kamat, Jianjun Gao, Arlene Siefker-Radtke, Bogdan Cz...> ;American Journal of Clinical Pathology. 2022 Aug 4
• 14 citations
  Impact of Somatic Mutations on Survival Outcomes in Patients With Anaplastic Thyroid Carcinoma.
  Jennifer Rui Wang, Matthew Montierth, Li Xu, Maitrayee Goswami, Xiao Zhao, Gilbert Cote, Wenyi Wang, Priyanka Iyer, Ramona Dadu, Naifa L Busaidy, Stephen Y Lai, Neil D...> ;JCO Precision Oncology. 2022 Aug 1
• 31 citations
  Poziotinib for EGFR exon 20-mutant NSCLC: Clinical efficacy, resistance mechanisms, and impact of insertion location on drug sensitivity.
  Yasir Y Elamin, Jacqulyne P Robichaux, Brett W Carter, Mehmet Altan, Hai Tran, Don L Gibbons, Simon Heeke, Frank V Fossella, Vincent K Lam, Xiuning Le, Marcelo V Negra...> ;Cancer Cell. 2022 Jul 11
• 37 citations
  Actionable Tumor Alterations and Treatment Protocol Enrollment of Pediatric and Young Adult Patients With Refractory Cancers in the National Cancer Institute-Children'...
  D Williams Parsons, Katherine A Janeway, David R Patton, Cynthia L Winter, Brent Coffey, P Mickey Williams, Sinchita Roy-Chowdhuri, Gregory J Tsongalis, Mark Routbort,...> ;Journal of Clinical Oncology. 2022 Jul 10
• 39 citations
  TP53 copy number and protein expression inform mutation status across risk categories in acute myeloid leukemia.
  Mehrnoosh Tashakori, Tapan Kadia, Sanam Loghavi, Naval Daver, Rashmi Kanagal-Shamanna, Sherry Pierce, Dawen Sui, Peng Wei, Farnoosh Khodakarami, Zhenya Tang, Mark Rout...> ;Blood. 2022 Jul 7
• Clinicopathologic spectrum of myeloid neoplasms with concurrent myeloproliferative neoplasm driver mutations and SRSF2 mutations.
  Mehrnoosh Tashakori, Joseph D Khoury, Mark J Routbort, Keyur P Patel, Sa A Wang, Chi Young Ok, Siba El-Hussein, Rashmi Kanagal-Shamanna, Rajyalakshmi Luthra, Shimin Hu...> ;Modern Pathology. 2022 Nov 1
• 7 citations
  Immunohistochemical loss of enhancer of Zeste Homolog 2 (EZH2) protein expression correlates with EZH2 alterations and portends a worse outcome in myelodysplastic synd...
  Ali Sakhdari, Caleb Class, Guillermo Montalban-Bravo, Koji Sasaki, Carlos E Bueso-Ramos, Keyur P Patel, Mark J Routbort, Sanam Loghavi, Chi Young Ok, Andres Quesada, J...> ;Modern Pathology. 2022 Sep 1
• 1 citations
  Landscape of NOTCH1 mutations and co-occurring biomarker alterations in chronic lymphocytic leukemia.
  Fatima Zahra Jelloul, Richard Yang, Sofia Garces, Rashmi Kanagal-Shamanna, Chi Y Ok, Sanam Loghavi, Mark J Routbort, Zhuang Zuo, C Cameron Yin, Kristen Floyd, Roland L...> ;Leukemia Research. 2022 May 1
• 1 citations
  Correction to: Myelodysplastic/myeloproliferative neoplasms-unclassifiable with isolated isochromosome 17q represents a distinct clinico-biologic subset: a multi-insti...
  Rashmi Kanagal-Shamanna, Attilio Orazi, Robert P Hasserjian, Daniel A Arber, Kaaren Reichard, Eric D Hsi, Adam Bagg, Heesun Joyce Rogers, Julia Geyer, Faezeh Darbaniya...> ;Modern Pathology. 2022 May 1
• 1 citations
  Non-coding NOTCH1 mutations in chronic lymphocytic leukemia negatively impact prognosis.
  Fatima Zahra Jelloul, Richard K Yang, Peng Wang, Sofia Garces, Rashmi Kanagal-Shamanna, Chi Y Ok, Sanam Loghavi, Mark J Routbort, Zhuang Zuo, Cheng Cameron Yin, Kriste...> ;American Journal of Hematology. 2022 Mar 1
• 8 citations
  Acquired WT1 mutations contribute to relapse of NPM1-mutated acute myeloid leukemia following allogeneic hematopoietic stem cell transplant.
  Siba El Hussein, Courtney D DiNardo, Koichi Takahashi, Joseph D Khoury, Hong Fang, Ken Furudate, Kirill A Lyapichev, Sofia Garces, Rashmi Kanagal-Shamanna, Chi Young O...> ;Bone Marrow Transplantation. 2022 Mar 1
• 8 citations
  Myelodysplastic/myeloproliferative neoplasms-unclassifiable with isolated isochromosome 17q represents a distinct clinico-biologic subset: a multi-institutional collab...
  Rashmi Kanagal-Shamanna, Attilio Orazi, Robert P. Hasserjian, Daniel A. Arber, Kaaren K. Reichard, Eric D. Hsi, Adam Bagg, Heesun J. Rogers, Julia T. Geyer, Faezeh Dar...> ;Modern Pathology. 2021 Nov 13
• 17 citations
  Only SF3B1 mutation involving K700E independently predicts overall survival in myelodysplastic syndromes
  Rashmi Kanagal-Shamanna, Guillermo Montalban-Bravo, Koji Sasaki, Faezeh Darbaniyan, Elias Jabbour, Carlos E. Bueso-Ramos, Yue Wei, Kelly S. Chien, Tapan M. Kadia, Farh...> ;Cancer. 2021 Oct 1
• 6 citations
  Evolutionary action score identifies a subset of TP53 mutated myelodysplastic syndrome with favorable prognosis.
  Rashmi Kanagal-Shamanna, Guillermo Montalban-Bravo, Panagiotis Katsonis, Koji Sasaki, Caleb A. Class, Elias Jabbour, David A. Sallman, Anthony M. Hunter, Christopher B...> ;Blood Cancer Journal. 2021 Mar 6
• 35 citations
  Next-Generation Sequencing of DDX41 in Myeloid Neoplasms Leads to Increased Detection of Germline Alterations.
  Sarah A. Bannon, Mark J. Routbort, Guillermo Montalban-Bravo, Rohtesh S. Mehta, Fatima Zahra Jelloul, Koichi Takahashi, Naval Daver, Betul Oran, Naveen Pemmaraju, Gaut...> ;Frontiers in Oncology. 2021 Jan 28
• 7 citations
  Factors impacting clinically relevant rna fusion assays using next-generation sequencing
  Nisha S. Ramani, Keyur P. Patel, Mark J. Routbort, Héctor M. Alvarez, Russell Broaddus, Hui Chen, Asif Rashid, Alexander J. Lazar, Francis A. San Lucas, Hui Yao, Jawad...> ;Archives of Pathology & Laboratory Medicine. 2021 Nov 1
• Join now to see all

Journal Articles

• Distinct Biological Types of Ocular Adnexal Sebaceous Carcinoma: HPV-Driven and Virus-Negative Tumors Arise Through Non-Overlapping Molecular-Genetic Alterations  
  Mark J Routbort, Diana Bell, Victor G Prieto, Michael T Tetzlaff, Anna Yemelyanova, Bita Esmaeli, Clinical Cancer Research
• Implementation of biomarker-driven cancer therapy: existing tools and remaining gaps  
  Bailey AM, Mao Y, Zeng J, Holla V, Johnson A, Brusco L, Chen K, Mendelsohn J, Routbort MJ, Mills GB, Meric-Bernstam F, Discov Med, 1/1/2014
• Quantitative assessment of mutant allele burden in solid tumors by semiconductor-based next-generation sequencing  
  Portier BP, Kanagal-Shamanna R, Luthra R, Singh R, Routbort MJ, Handal B, Reddy N, Barkoh BA, Zuo Z, Medeiros LJ, Aldape K, Patel KP, Am J Clin Pathol, 1/1/2014
• BRAF Kinase domain mutations are present in a subset of chronic myelomonocytic leukemia with Wild-Type RAS  
  Zhang L, Singh RR, Patel KP, Stingo F, Routbort M, You MJ, Miranda RN, Garcia-Manero G, Kantarjian HM, Medeiros LJ, Luthra R, Khoury JD, Am J Hematol, 1/1/2014
• Beyond BRAF(V600): clinical mutation panel testing by next-generation sequencing in advanced melanoma  
  Siroy AE, Boland GM, Milton DR, Roszik J, Frankian S, Malke J, Haydu L, Prieto VG, Tetzlaff M, Ivan D, Wang WL, Torres-Cabala C, Curry J, Roy-Chowdhuri S, Broaddus R, ..., J Invest Dermatol, 1/1/2014
• Absence of terminal deoxynucleotidyl transferase expression identifies a subset of high-risk adult T-lymphoblastic leukemia/lymphoma  
  Zhou Y, Fan X, Routbort M, Cameron Yin C, Singh R, Bueso-Ramos C, Thomas DA, Milton DR, Medeiros LJ, Lin P, Mod Pathol, 1/1/2013
• Next-generation sequencing-based multi-gene mutation profiling of solid tumors using fine needle aspiration samples: promises and challenges for routine clinical diagn...  
  Kanagal-Shamanna R, Portier BP, Singh RR, Routbort MJ, Aldape KD, Handal BA, Rahimi H, Reddy NG, Barkoh BA, Mishra BM, Paladugu AV, Manekia JH, Kalhor N, Chowdhuri SR,..., Mod Pathol, 1/1/2013
• TET2 mutations, myelodysplastic features, and a distinct immunoprofile characterize blastic plasmacytoid dendritic cell neoplasm in the bone marrow  
  Alayed K, Patel KP, Konoplev SN, Singh R, Routbort MJ, Reddy N, Pemmaraju N, Zhang L, Al Shaikh A, Aladily T, Jain N, Luthra R, Medeiros LJ, Khoury JD, Am J Hematol, 1/1/2013
• Clinical Validation of a Next Generation Sequencing Screen for Mutational Hotspots in 46 Cancer-related Genes  
  Singh RR, Patel KP, Routbort MJ, Reddy NG, Barkoh BA, Handal B, Kanagal-Shamanna R, Greaves WO, Medeiros LJ, Aldape KD, Luthra R, J Mol Diagn, 1/1/2013
• Next Generation Sequencing based Multi-Gene Mutational Screen for Acute Myeloid Leukemia using MiSeq: Applicability for Diagnostics and Disease Monitoring  
  Luthra R, Patel KP, Reddy NG, Haghshenas V, Routbort MJ, Harmon MA, Barkoh BA, Kanagal-Shamanna R, Ravandi F, Cortes JE, Kantarjian HM, Medeiros LJ, Singh RR, Haematologica, 1/1/2013
• Real-time process defect collection within the anatomic pathology aboratory to facilitate informatics driven workflow optimization  
  Riben M, Routbort M, Nesbitt L, Ninan S, AMIA Annu Symp Proc, 1/1/2008
• High frequency of NPM1 gene mutations in acute myeloid leukemia with prominent nuclear invaginations ("cuplike" nuclei)  
  Chen W, Rassidakis GZ, Li J, Routbort M, Jones D, Kantarjian H, Medeiros LJ, Bueso-Ramos CE, Blood, 1/1/2006
• Neurovirulence determinants of genetically engineered Theiler viruses  
  Fu JL, Stein S, Rosenstein L, Bodwell T, Routbort M, Semler BL, Roos RP, Proc Natl Acad Sci USA, 1/1/1990
• Pulmonary granulocytic sarcoma (chloroma) mimicking an opportunistic infection in a patient with acute myeloid leukemia  
  Guimaraes MD, Marchiori E, Marom EM, Routbort MJ, Godoy MC, Ann Hematol
• Join now to see all

Books/Book Chapters

• Pathology Informatics: Theory and Practice 
  Chapter: Networks and Workstations 
  Routbort MJASCP Press2012
• Excitatory amino acids and the cerebral cortex 
  Chapter: Excitatory amino acids and use-dependent plasticity: epileptogenesis 
  Page 313 - 323Routbort MJ, McNamara JOMIT Press1996

Abstracts/Posters

• The Impact of PHF6 Mutations in Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia, and Acute Myeloid Leukemia
  Mark Routbort, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Evolutionary Action (EA) Score of TP53 Mutations Defines Prognostic Subsets within TP53 Mutated Myelodysplastic Syndromes and Acute Myeloid Leukemia
  Mark Routbort, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Clinical Next Generation Sequencing of Sarcomas: Initial experience of 133 Cases
  AA Salim, WL Wang, KD Aldape, R Luthra, M Routbort, A Lazar, Modern Pathology, 1/1/2014
• Clinical Next Generation Sequencing Reveals Divergent Mutation Patterns in BRAF V500, BRAF Non-V600, and NRAS Mutations in Advanced Melanoma
  AE Siroy, VG Prieto, JE Gershenwald, SE Woodman, J Roszik, KD Aldape, R Luthra, KP Patel, MJ Routbort, MA Davies, AJ Lazar, Modern Pathology, 1/1/2014
• Clonal evolution of cancer examined via next-generation sequencing of 266 paired primary and metastatic tumors
  R Goswami, KP Patel, KD Aldape, R Singh, KJ Jabbar, S Kopetz, R Alvarez, M Davies, V Subbiah, KR Shaw, F Meric-Bernstam, R Luthra, M Routbort, Modern Pathology, 1/1/2014
• Comparison of Next Generation Sequencing Mutation Profiling with BRAF and IDH1 Mutation Specific Immunohistochemistry
  KJ Jabbar, R Luthra, K Patel, R Singh, R Goswami, LJ Medeiros, K Aldape, M Routbort, Modern Pathology, 1/1/2014
• De Novo Acute Myeloid Leukemia with DNMT3A, FLT3, and NPM1 Mutations
  S Loghavi, Z Zuo, L Zhang, F Stingo, KP Patel, RR Singh, R Luthra, MJ Routbort, J Medeiros, JE Cortes, F Ravandi-Kashani, HM Kantarjian, JD Khoury, Modern Pathology, 1/1/2014
• Gene Amplification Patterns Identified By Next Generation Sequencing in a Large Tumor Cohort
  KJ Jabbar, K Patel,K Aldape, R Broaddus, K Shaw, F Meric-Bernstam, S Roy Chowdhuri, A Lazar, R Goswami, LJ Medeiros, R Luthra, MJ Routbort, Modern Pathology, 1/1/2014
• Multigene Mutation Analysis Using Next Generation Sequencing in AML and MDS
  CY Ok, R Kanagal-Shamanna, R Singh, KD Aldape, KP Patel, M Routbort, R Luthra, LJ Medeiros, SA Wang, Modern Pathology, 1/1/2014
• Multi-gene Mutational Profiling of Breast Carcinoma using Next Generation Sequencing
  SR Chowdhuri, M Routbort, K Patel, R Singh, R Broaddus, A Lazar, A Sahin, G Mills, J Mendelsohn, F Meric-Bernstam, K Aldape, R Luthra, Modern Pathology, 1/1/2014
• Novel Mutations in Therapy-Related and De Novo Myelodysplasia: Results from a Next-Generation Sequencing Pilot Study
  R Goswami, C Ok, K Patel, S Wang, M Routbort, J Manekia, KJ Jabbar, B Barkho, LJ Medeiros, R Singh, R Luthra, Modern Pathology, 1/1/2014
• The Art and Science of Next Generation Sequencing Data Interpretation: Value of Pattern Recognition and Statistical Analysis in Distinguishing True Mutations from Arti...
  S Roy Chowdhuri, M Routbort, R Singh, K Aldape, R Broaddus, A Lazar, LJ Medeiros, B Barkho, N Reddy, R Luthra, KP Patel, Modern Pathology, 1/1/2014
• Next Generation Sequencing of a Large Cohort of Solid Tumors Reveals IDH1 Mutations Present in Melanoma at a Higher Frequency than Expected
  Bryce P. Portier, Keyur P. Patel, Rajesh Singh, Mark Routbort, Brian Handal, Bedia A. Barkoh, Neelima Reddy, Alex Lazar, Michael Davies, L. Jeffrey Medeiros, Ken Aldap..., United States and Canadian Assoc Pathology Annual, 1/1/2013
• Quantitative Assessment of Mutant Allele Burden in Solid Tumors by Semiconductor Based Multi-Gene Next Generation Sequencing
  Bryce P. Portier, Rajyalakshmi Luthra, Rajesh Singh, Mark Routbort, Brian Handal, Neeli Reddy, Bedia Barkoh, Zhuang Zuo, Jeffery Medeiros, Ken Aldape and Keyur Patel, United States and Canadian Assoc Pathology Annual, 1/1/2013
• RAS Mutation Is a Poor Prognostic Factor in Patients with Chronic Myelomonocytic Leukemia
  Liping Zhang, Tariq Aladily, Zaher Chakhachiro, Hui Yao, Xiaoping Su, Mark Routbort, Sa Wang, Raja Luthra, Roberto Miranda, L. Jeffrey Medeiros, Carlos Bueso-Ramos, Jo..., United States and Canadian Assoc Pathology Annual, 1/1/2013
• Identification of HER-2/neu amplification using amplicon based benchtop next generation sequencing
  Portier BP, Patel K, Medeiros LJ, Singh R, Aldape KJ, Hamilton S, Luthra R, Routbort M, San Antonio Breast Cancer Symposium, 1/1/2013
• Clinical Validation of a 46 Cancer Gene Mutation Panel using SemiConductor Based Next-Generation Sequencing Technology
  R.R. Singh, N.G. Reddy, B. Barkoh, B. Handal, K.P. Patel, M. Routbort, K.D. Aldape, J.L. Medeiros, R. Luthra, Journal Molec Diag, 1/1/2012
• Comparison of Next Generation Sequencing Platforms for Multi-Gene Mutational Profiling of Hematologic Malignancies in a Clinical Diagnostics Laboratory
  K.P. Patel, R. Singh, N. Reddy, M. Routbort, K. Aldape, L. Medeiros, R. Sargent, S.S. Chen, C. Yin, J. Zuo, B.A. Barkoh, B. Handal, A. Paladugu, R. Patel, H. Rahimi, ..., Journal Molec Diag, 1/1/2012
• Does Formalin-Fixation and Paraffin-Embedding Affect Genotyping by Next Generation Sequencing?
  N.G. Reddy, R. Singh, K.P. Patel, F. Grant, H. Rahimi, M.A. Harmon, B. Handal, B.A. Barkoh, M. Routbort, K.D. Aldape, J.L. Medeiros, R. Luthra, Journal Molec Diag, 1/1/2012
• OncoSeek - A Versatile Annotation and Reporting System for Next Generation Sequencing-Based Clinical Mutation Analysis of Cancer Specimens
  Mark Routbort, Brian Handal, Keyur P. Patel, Rajesh Singh, Kenneth Aldape, Neelima Reddy, Bedia Barkoh, Michael Riben, L. Jeffrey Medeiros, Rajyalakshmi Luthra, Journal Molec Diag, 1/1/2012
• Application of Next-Generation Sequencing in Using Fine Needle Aspiration Smears and Cell Blocks from Solid Tumors
  R. Kanagal-Shamanna, R.R. Singh, M.J. Routbort, K.D. Aldape, B. Handal, H. Rahimi, N.G. Reddy, B.A. Barkoh, B. Mishra, A.V. Paladugu, J. Manekia, G.A. Staerkel, L. M..., Journal Molec Diag, 1/1/2012
• Pre-analytic Process Improvements for Molecular Testing improves Turn Around time for Results
  Middleton L, Puig P, Hamilton S, Routbort M, Luthra R, Rashid A, Reynolds A, Heydon L, Dunn J, Hiumin L, Jackson S, Guerreo J, Lewing C, Bowman C, Ponder J, Cook P, Ph..., University of Texas System Clinical Safety and Effectiveness Conference, 1/1/2011
• Reactivation of hepatitis B infection among patients with cancer
  Hwang J, Fisch M, Zhang H, Kallen M, Routbort M, Vierling LS, Suarez-Almazo M, J Clin Oncol, 1/1/2011
• Hepatitis B screening and positivity prior to chemotherapy
  Hwang JP, Fisch MJ, Zhang H, Routbort MJ, Lal LS, Vierling JM, Suarez-Almazor M, J Clin Oncol, 1/1/2010
• Integration of Digital Pathology Systems: A Software Development Approach
  Routbort MJ, Ninan S, Riben M, Pathology Informatics, 1/1/2010
• Join now to see all

Lectures

• Building a Data Warehouse for Clinical Next Generation Sequencing Data 
  Boston, MA - 1/26/2014
• Informatics Driven Molecular Pathology Workshop 
  Pittsburgh, PA - 1/13/2014
• LIS Interfaces: Basics, Implementation and Pitfalls 
  Pittsburgh, PA - 1/13/2014
• The Intersection of Pathology Informatics and Molecular Diagnostics: When the Bit hits the SNP 
  San Diego, CA - 1/1/2014
• Next Generation Sequencing in Leukemia: Recent Advances in Clinical Applications 
  Houston, TX - 1/26/2013
• Clinical next generation sequencing of solid tumors: Initial MD Anderson experiences 
  Houston, TX - 1/19/2013
• Clinical Informatics in the Era of Genomic Medicine 
  Phoenix, AZ - 1/14/2013
• The information overload from molecular testing: Possible IT solutions for effective consultation 
  Asheville, NC - 1/7/2013
• Next generation sequencing analysis of tumors in the clinical laboratory 
  Durham, NC - 1/5/2013
• Information management for clinical molecular testing 
  Houston, TX - 1/4/2013
• Next generation sequencing and cancer pathology: Informatics challenges and advances 
  Houston, TX - 1/7/2012
• Bar-code driven AP workflow: Step by step 
  Pittsburgh, PA - 1/20/2009
• Advantages and integration of multi-vendor LIS environments 
  Boston, MA - 1/20/2009
• Outside the box interfaces: Agile techniques for getting data in and out of the LIS 
  Pittsburgh, PA - 1/19/2008
• Service-Oriented Architectures 
  Houston, TX - 1/17/2007
• Pathology Informatics: USA 
  Brisbane, Australia - 1/17/2007
• Anatomic Pathology Informatics and Imaging Support for Translational Medicine 
  Pittsburgh, PA - 1/12/2007
• Surgical pathology informatics: what's new and what's next 
  Mexico - 1/1/2007
• SQL Comparator: An open source tool for minimal change database validation 
  Pittsburgh, PA - 1/1/2007
• Informatics 101 
  1/16/2006
• Introducing new technology into an old grossing facility: Hands free computing to facilitate grossing workflow 
  Pittsburgh, PA - 1/1/2006
• Optimized document management in anatomic pathology: Two paths to a common workflow with analysis of benefits 
  Pittsburgh, PA - 1/1/2006
• PathStation-A pathoogy workflow integration engine using an enterprise application mash-up design pattern 
  Pittsburgh, PA - 1/1/2006
• A state pattern recognition and extraction engine tool for legacy system interoperability 
  Pittsburgh, PA - 1/1/2006
• Out of the LIS and into the EMR: Taking control of the functional display of anatomic pathology data 
  Pittsburgh, PA - 1/1/2005
• Join now to see all

Other

• Comparator: An open source tool for miminal change database validation 
  Routbort MJ
  http://sourceforge.net/projects/sqlcomparator
• OncoSeek: A clinical genomic analysis and reporting tool 
  Routbort MJ
  https://github.com/routbort/OncoSeek